Advent To Buy Suven Pharma In A Rs 9,589-Crore Deal

NDTV Profit

Published On

26 Dec 2022, 04:51 PM IST

Last Updated On

26 Dec 2022, 04:51 PM IST

Global private equity firm Advent International will acquire a 50.1% stake in Suven Pharma, buying 12.75 crore shares for a total of Rs 6,313 crore. Suven Pharma MD Venkateswarlu Jasti discusses the acquisition.

RECOMMENDED FOR YOU

Glenmark Pharma Shares Hit Life High After License Deal With AbbVie For Cancer Drug

timelogo

Emcure Pharmaceuticals Bulk Deal: BC Investments Offloads Stake For Rs 563 Crore

timelogo

Solara Active Pharma Block Deal: Promoter Entity Buys 4.16% Stake For Rs 99 Crore

timelogo

Aditya Birla Capital Block Deal: Advent International Offers 1.4% Stake For Rs 856 Crore

timelogo